Why Admixture Matters in Genetically-Guided Therapy: Missed Targets in the COAG and EU-PACT Trials
PDF

Keywords

pharmacogenetics
admixture
warfarin
Hispanics
genotyping
clinical trials

How to Cite

Duconge, J., Cadilla, C. L., Seip, R. L., & Ruaño, G. (2015). Why Admixture Matters in Genetically-Guided Therapy: Missed Targets in the COAG and EU-PACT Trials. Puerto Rico Health Sciences Journal, 34(3). Retrieved from https://prhsj.rcm.upr.edu/index.php/prhsj/article/view/1185
PDF
Authors who publish with this journal agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).